Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc. · Short Volume

Track XLO — free
$8.01 +0.00 (+0.00%)
Market Cap
$47.07M
Shares
5.78M
Volume · Oct 28 16.68K Avg daily vol (3M) 12.49K

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-10-28 3,668 0 9,705 37.8%
2026-10-27 5,588 0 11,770 47.5%
2026-10-26 6,196 0 17,020 36.4%
2026-10-23 2,853 200 7,710 37.0%
2026-10-22 1,080 0 3,491 30.9%
2026-10-21 6,460 0 13,791 46.8%
2026-10-20 2,041 0 5,210 39.2%
2026-10-19 1,075 0 5,425 19.8%
2026-10-16 591 0 3,496 16.9%
2026-10-15 1,755 0 4,997 35.1%
2026-10-14 1,533 0 2,900 52.9%
2026-10-13 1,392 0 4,889 28.5%
2026-10-12 943 0 3,408 27.7%
2026-10-09 581 0 3,166 18.4%
2026-10-08 1,014 0 3,147 32.2%
2026-10-07 24 0 166 14.4%
2026-10-06 104 0 2,272 4.6%
2026-10-05 1,284 0 1,890 67.9%
2026-10-02 1,497 0 2,327 64.3%
2026-10-01 599 0 2,101 28.5%
2026-09-30 51 0 677 7.5%
2026-09-29 589 0 1,084 54.3%
2026-09-28 691 0 2,115 32.7%
2026-09-25 1,446 0 1,909 75.7%
2026-09-24 2,672 500 5,725 46.7%
2026-09-23 131 0 168 78.2%
2026-09-22 1,334 0 2,851 46.8%
2026-09-21 860 0 4,100 21.0%
2026-09-18 1,011 50 4,208 24.0%
2026-09-17 762 0 4,709 16.2%
2026-09-16 386 0 2,903 13.3%
2026-09-15 1,974 0 6,964 28.3%
2026-09-14 2,426 0 4,776 50.8%
2026-09-11 330 0 2,633 12.5%
2026-09-10 3,184 0 8,415 37.8%
2026-09-09 766 0 8,005 9.6%
2026-09-08 681 0 6,579 10.4%
2026-09-04 573 0 3,246 17.7%
2026-09-03 1,819 0 2,832 64.2%
2026-09-02 267 0 1,547 17.3%
2026-09-01 4,640 0 25,130 18.5%
2026-08-31 871 0 4,174 20.9%
2026-08-28 32 0 2,942 1.1%
2026-08-27 1,651 179 4,330 38.1%
2026-08-26 1,564 0 3,389 46.1%
2026-08-25 705 0 2,449 28.8%
2026-08-24 211 0 1,653 12.8%
2026-08-21 312 0 1,610 19.4%
2026-08-20 226 0 3,011 7.5%
2026-08-19 1,358 0 3,297 41.2%
Showing 1–50 of 66 days
Key facts CIK 1840233 CUSIP 98422T209 Visit website Investor relations